Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 10 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: A0A3S7WT35
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.423 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.509 |
CLV_PCSK_FUR_1 | 213 | 217 | PF00082 | 0.432 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.453 |
CLV_PCSK_KEX2_1 | 215 | 217 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.497 |
CLV_PCSK_PC1ET2_1 | 215 | 217 | PF00082 | 0.464 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.295 |
CLV_PCSK_SKI1_1 | 183 | 187 | PF00082 | 0.422 |
CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 225 | 229 | PF00082 | 0.537 |
DEG_APCC_DBOX_1 | 150 | 158 | PF00400 | 0.553 |
DEG_SPOP_SBC_1 | 170 | 174 | PF00917 | 0.370 |
DOC_MAPK_gen_1 | 147 | 156 | PF00069 | 0.508 |
DOC_MAPK_gen_1 | 181 | 190 | PF00069 | 0.309 |
DOC_MAPK_gen_1 | 94 | 103 | PF00069 | 0.667 |
DOC_MAPK_MEF2A_6 | 181 | 190 | PF00069 | 0.323 |
DOC_MAPK_RevD_3 | 199 | 213 | PF00069 | 0.620 |
DOC_PP1_SILK_1 | 23 | 28 | PF00149 | 0.421 |
DOC_PP2B_LxvP_1 | 26 | 29 | PF13499 | 0.316 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.627 |
LIG_14-3-3_CanoR_1 | 151 | 157 | PF00244 | 0.494 |
LIG_14-3-3_CanoR_1 | 169 | 179 | PF00244 | 0.152 |
LIG_14-3-3_CanoR_1 | 97 | 102 | PF00244 | 0.681 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.453 |
LIG_DLG_GKlike_1 | 97 | 105 | PF00625 | 0.687 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.662 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.330 |
LIG_FHA_1 | 170 | 176 | PF00498 | 0.291 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.381 |
LIG_FHA_2 | 119 | 125 | PF00498 | 0.668 |
LIG_GBD_Chelix_1 | 167 | 175 | PF00786 | 0.419 |
LIG_LIR_Gen_1 | 155 | 163 | PF02991 | 0.307 |
LIG_LIR_Gen_1 | 16 | 25 | PF02991 | 0.389 |
LIG_LIR_Gen_1 | 74 | 85 | PF02991 | 0.359 |
LIG_LIR_LC3C_4 | 79 | 84 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 155 | 159 | PF02991 | 0.316 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.342 |
LIG_NRBOX | 44 | 50 | PF00104 | 0.234 |
LIG_NRBOX | 81 | 87 | PF00104 | 0.421 |
LIG_Pex14_2 | 132 | 136 | PF04695 | 0.553 |
LIG_Pex14_2 | 156 | 160 | PF04695 | 0.357 |
LIG_SH2_CRK | 17 | 21 | PF00017 | 0.300 |
LIG_SH2_GRB2like | 143 | 146 | PF00017 | 0.512 |
LIG_SH2_SRC | 55 | 58 | PF00017 | 0.416 |
LIG_SH2_STAP1 | 17 | 21 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.538 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.387 |
LIG_SUMO_SIM_anti_2 | 41 | 47 | PF11976 | 0.496 |
LIG_SUMO_SIM_par_1 | 47 | 54 | PF11976 | 0.324 |
LIG_TYR_ITIM | 15 | 20 | PF00017 | 0.300 |
LIG_TYR_ITIM | 204 | 209 | PF00017 | 0.544 |
LIG_UBA3_1 | 85 | 91 | PF00899 | 0.416 |
LIG_ULM_U2AF65_1 | 215 | 220 | PF00076 | 0.573 |
LIG_WRC_WIRS_1 | 156 | 161 | PF05994 | 0.325 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.316 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.472 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.309 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.660 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.426 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.263 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.362 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.357 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.331 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.668 |
MOD_LATS_1 | 221 | 227 | PF00433 | 0.652 |
MOD_N-GLC_1 | 175 | 180 | PF02516 | 0.456 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.294 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.631 |
MOD_PKA_1 | 97 | 103 | PF00069 | 0.691 |
MOD_PKA_2 | 97 | 103 | PF00069 | 0.719 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.266 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.451 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.405 |
MOD_Plk_4 | 21 | 27 | PF00069 | 0.291 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.385 |
MOD_Plk_4 | 51 | 57 | PF00069 | 0.385 |
TRG_ENDOCYTIC_2 | 17 | 20 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 206 | 209 | PF00928 | 0.643 |
TRG_ER_diArg_1 | 146 | 149 | PF00400 | 0.496 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.654 |
TRG_NLS_MonoExtN_4 | 212 | 219 | PF00514 | 0.671 |
TRG_Pf-PMV_PEXEL_1 | 120 | 124 | PF00026 | 0.456 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2I8 | Leptomonas seymouri | 70% | 100% |
A0A0S4JQ57 | Bodo saltans | 53% | 82% |
A0A1X0NQ59 | Trypanosomatidae | 48% | 91% |
A0A422MWP8 | Trypanosoma rangeli | 49% | 94% |
A4H7R3 | Leishmania braziliensis | 78% | 100% |
A4HW51 | Leishmania infantum | 100% | 100% |
C9ZSW8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 96% |
E9APV5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
O75352 | Homo sapiens | 30% | 93% |
Q20157 | Caenorhabditis elegans | 31% | 95% |
Q4QFM6 | Leishmania major | 93% | 100% |
Q60441 | Cricetulus griseus | 30% | 93% |
Q8VY63 | Arabidopsis thaliana | 33% | 98% |
Q9LTI3 | Arabidopsis thaliana | 30% | 96% |
Q9R0Q9 | Mus musculus | 30% | 93% |
Q9VMW8 | Drosophila melanogaster | 28% | 91% |
V5BJ03 | Trypanosoma cruzi | 51% | 91% |